This white paper, Low-Dose Radiation Therapy (LDRT) for Benign Musculoskeletal Disorders, is an essential resource for primary care physicians, rheumatologists, orthopedic surgeons, hospital administrators, and insurance providers who are interested in understanding how radiotherapy can help treat patients with chronic pain.
Fig. 2
Authored by leading LDRT experts, including Dr. Bobby Koneru and Dr. Richard Shaffer, it presents the clinical data supporting the use of LDRT for conditions such as osteoarthritis, plantar fasciitis, and tendinopathy – common diagnoses often inadequately treated by conventional methods.
The paper outlines international and U.S.-based data showing that more than 70% of patients experience durable pain relief for 1–2 years with LDRT, without the systemic risks associated with NSAIDs, corticosteroids, or surgery. It details LDRT’s anti-inflammatory mechanisms, safety profile, and practical treatment protocols (3–6 Gy total dose over 2–3 weeks).
Importantly, it highlights LDRT’s cost-effectiveness and outlines reimbursement pathways using existing CPT codes. With growing interest in non-opioid and minimally invasive therapies, this document provides additional information to support the use of LDRT in clinical practice. It also provides a clear framework for advocacy with insurers, positioning LDRT as a value-based option aligned with global standards.
View the entire publication here.